Literature DB >> 2493872

Physical condition, longevity, and social performance of Dutch haemophiliacs, 1972-85.

C Smit1, F R Rosendaal, I Varekamp, A Bröcker-Vriends, H Van Dijck, T P Suurmeijer, E Briët.   

Abstract

A study was carried out among haemophiliacs in The Netherlands to evaluate the effect of modern substitution treatment (replacing the missing clotting factors) on medical and social performance. Three questionnaires were sent between 1972 and 1985. The use of prophylactic treatment in the group of patients with severe and moderately severe haemophilia increased from 21% (n = 242) in 1972 to 36% (n = 559) in 1985. Home treatment programmes increased from 4% to 53%. Overall mortality was 2.1 times higher than in the general male population, which leads to a calculated life expectancy of 66 years compared with 74 years in the general male population. Severe joint impairment was prominent in the older age groups, reflecting insufficient treatment in the past. A sharp decrease in the use of inpatient and outpatient hospital facilities was observed as well as much less absence from school and work. It is concluded that the high costs of modern substitution treatment are fully justified.

Entities:  

Mesh:

Year:  1989        PMID: 2493872      PMCID: PMC1835514          DOI: 10.1136/bmj.298.6668.235

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  14 in total

1.  Smoking and death rates; report on forty-four months of follow-up of 187,783 men. I. Total mortality.

Authors:  E C HAMMOND; D HORN
Journal:  J Am Med Assoc       Date:  1958-03-08

2.  Cost of management of patients with haemophilia.

Authors:  F Carter; C D Forbes; J D MacFarlane; C R Prentice
Journal:  Br Med J       Date:  1976-08-21

3.  Hemophilia, beaten on one front, is beset on others.

Authors:  M F Goldsmith
Journal:  JAMA       Date:  1986-12-19       Impact factor: 56.272

4.  Hemophilia home transfusion program: analysis of cost data.

Authors:  J Lazerson
Journal:  J Pediatr       Date:  1973-10       Impact factor: 4.406

5.  Life expectancy of Swedish haemophiliacs, 1831-1980.

Authors:  S A Larsson
Journal:  Br J Haematol       Date:  1985-04       Impact factor: 6.998

6.  Lessons from hemophilia.

Authors:  L M Aledort
Journal:  N Engl J Med       Date:  1982-03-11       Impact factor: 91.245

7.  Improving prospects for employment of the haemophiliac.

Authors:  J Stuart; C D Forbes; P Jones; G Lane; C R Rizza; S Wilkes
Journal:  Br Med J       Date:  1980-05-10

8.  Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate.

Authors:  J J Goedert; M G Sarngadharan; M E Eyster; S H Weiss; A J Bodner; R C Gallo; W A Blattner
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

9.  Acquired immunodeficiency syndrome among patients attending hemophilia treatment centers and mortality experience of hemophiliacs in the United States.

Authors:  R E Johnson; D N Lawrence; B L Evatt; D J Bregman; L D Zyla; J W Curran; L M Aledort; M E Eyster; A P Brownstein; C J Carman
Journal:  Am J Epidemiol       Date:  1985-06       Impact factor: 4.897

10.  Socioeconomic evaluation of a state-funded comprehensive hemophilia-care program.

Authors:  P S Smith; N C Keyes; E N Forman
Journal:  N Engl J Med       Date:  1982-03-11       Impact factor: 91.245

View more
  6 in total

Review 1.  Hemophilia treatment in historical perspective: a review of medical and social developments.

Authors:  F R Rosendaal; C Smit; E Briët
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

2.  Sex ratio of the mutation frequencies in haemophilia A: estimation and meta-analysis.

Authors:  F R Rosendaal; A H Bröcker-Vriends; J C van Houwelingen; C Smit; I Varekamp; H van Dijck; T P Suurmeijer; J P Vandenbroucke; E Briët
Journal:  Hum Genet       Date:  1990-12       Impact factor: 4.132

3.  Inversions in the factor VIII gene: improvement of carrier detection and prenatal diagnosis in Dutch haemophilia A families.

Authors:  P P Deutz-Terlouw; M Losekoot; R Olmer; W C Pieneman; S de Vries-v d Weerd; E Briët; E Bakker
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

Review 4.  The contribution of DNA analysis to carrier detection and prenatal diagnosis of hemophilia A and B.

Authors:  A H Bröcker-Vriends; E Bakker; H H Kanhai; G J van Ommen; P H Reitsma; J J van de Kamp; E Briët
Journal:  Ann Hematol       Date:  1992-01       Impact factor: 3.673

Review 5.  Management of Hemophilia in Older Patients.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

6.  Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands study.

Authors:  Erna C van Balen; Shermarke Hassan; Cees Smit; Mariette H E Driessens; Erik A M Beckers; Michiel Coppens; Jeroen C Eikenboom; Hélène L Hooimeijer; Frank W G Leebeek; Evelien P Mauser-Bunschoten; Lize F D van Vulpen; Saskia E M Schols; Frits R Rosendaal; Johanna G van der Bom; Samantha C Gouw
Journal:  Res Pract Thromb Haemost       Date:  2022-08-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.